This was associated with a marked increase in LVESP and LVESPVR, although the latter did not reach statistical significance.
← all excerpts
The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure.
1
—
—